p>The aim of this study was to investigate microRNA (miRNA) differential expression in the two most common equine skin tumours, equine sarcoid (ES) and squ'/> Differentially expressed microRNAs, including a large microRNA cluster on chromosome 24, are associated with equine sarcoid and squamous cell carcinoma
首页> 外文期刊>Veterinary and Comparative Oncology >Differentially expressed microRNAs, including a large microRNA cluster on chromosome 24, are associated with equine sarcoid and squamous cell carcinoma
【24h】

Differentially expressed microRNAs, including a large microRNA cluster on chromosome 24, are associated with equine sarcoid and squamous cell carcinoma

机译:差异表达的microRNA,包括染色体24上的大型microRNA簇,与马术和鳞状细胞癌相关联

获取原文
获取原文并翻译 | 示例
           

摘要

abstract type="main" xml:lang="en"> p>The aim of this study was to investigate microRNA (miRNA) differential expression in the two most common equine skin tumours, equine sarcoid (ES) and squamous cell carcinoma (SCC), and its potential influence on the tumour microenvironment at post‐transcriptional level. We investigated miRNA fingerprints in four subgroups: mild (ESM) and aggressive (ESA) ES and ocular SCC (oSCC) and genital SCC (gSCC). Three tumours and three control samples were included in each of the four subgroups. Following next generation sequencing, miRNA differential expression analysis using DESeq2 was carried out. Pathways associated with the human mature homologues of identified dysregulated miRNAs were predicted using DIANA‐ miRPath v3.0. When comparing tumour vs control tissue, 57 miRNAs in ESM, six in ESA, 47 in oSCC and zero in gSCC were found to be differentially expressed and may thus serve as potential diagnostic tissue biomarkers. Whereas, ES lesions in general were associated with downregulation of the miR‐200 family, which may trigger epithelial‐mesenchymal transition, ESM lesions were associated with upregulation of the proposed tumour‐suppressive miRNA cluster on equine chromosome 24. In contrast, the oSCC tumours showed downregulation of this cluster as well as downregulation of the miR‐34 family, which may favour oSCC tumour cell metabolism. To further validate the proposed diagnostic miRNA fingerprints and their suggested biological effects, further miRNA studies need to be carried out in larger study cohorts./p> /abstract>
机译:&抽象类型=“main”xml:lang =“en”>& p> p> p>& p>在两个最常见的大麻皮肤肿瘤,马术(es)和鳞状中,研究MicroRNA(miRNA)差异表达。细胞癌(SCC)及其对转录后水平肿瘤微环境的潜在影响。我们研究了四个亚组中的miRNA指纹:轻度(ESM)和攻击性(ESA)ES和眼部SCC(OSCC)和生殖器SCC(GSCC)。在四个亚组中的每一个中包含三种肿瘤和三种对照样品。在下一代测序之后,进行使用DESEQ2的miRNA差异表达分析。使用Diana-MiRPath V3.0预测与鉴定的失去的miRNA的人成熟同源物相关的途径。当比较肿瘤VS对照组织时,发现57 mIRNA在ESM中的六个ESA中的六个,OSCC中的47个和GSCC中的零中差异表达,因此可以用作潜在的诊断组织生物标志物。而ES病变通常与miR-200家族的下调有关,其可能引发上皮 - 间充质转变,ESM病变与大型染色体24上提出的肿瘤抑制miRNA簇的上调相关。相反,OSCC肿瘤显示该群集的下调以及MIR-34家族的下调,这可能有利于OSCC肿瘤细胞代谢。为了进一步验证所提出的诊断miRNA指纹及其建议的生物效应,需要在较大的研究队列中进行进一步的miRNA研究。& /摘要>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号